Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05035823 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

StatusActive, Not Recruiting
PhaseNot applicable
Started2022-04-27
View on ClinicalTrials.gov ↗
The Synchron motor neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility. The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands.

Amendment history 1 change detected by DataLookout

2026-09-09
minor
Completion pushed: 2026-09 → 2028-09
Trial Details
NCT Number NCT05035823
Lead Sponsor Synchron Medical, Inc.
Conditions Neurologic Disorder, Paralysis, Paralysis; Stroke, Amyotrophic Lateral Sclerosis, Muscular Dystrophies, Spinal Cord Injuries, Stroke, Lacunar, Stroke Brainstem +4 more
Enrollment 6 participants
Start Date 2022-04-27
Primary Completion 2024-09-19 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-08